 Liver Neoplasms
"Liver Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the LIVER.
| Descriptor ID |
D008113
|
| MeSH Number(s) |
C04.588.274.623 C06.301.623 C06.552.697
|
| Concept/Terms |
Liver Neoplasms- Liver Neoplasms
- Neoplasms, Hepatic
- Neoplasms, Liver
- Liver Neoplasm
- Neoplasm, Liver
- Hepatic Neoplasms
- Hepatic Neoplasm
- Neoplasm, Hepatic
Cancer of Liver- Cancer of Liver
- Hepatocellular Cancer
- Cancers, Hepatocellular
- Hepatocellular Cancers
- Hepatic Cancer
- Cancer, Hepatic
- Cancers, Hepatic
- Hepatic Cancers
- Liver Cancer
- Cancer, Liver
- Cancers, Liver
- Liver Cancers
- Cancer of the Liver
- Cancer, Hepatocellular
|
Below are MeSH descriptors whose meaning is more general than "Liver Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Liver Neoplasms".
This graph shows the total number of publications written about "Liver Neoplasms" by people in this website by year, and whether "Liver Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 | | 1997 | 1 | 1 | 2 | | 1998 | 0 | 1 | 1 | | 1999 | 2 | 0 | 2 | | 2000 | 5 | 0 | 5 | | 2001 | 5 | 1 | 6 | | 2002 | 3 | 1 | 4 | | 2003 | 5 | 0 | 5 | | 2004 | 6 | 3 | 9 | | 2005 | 6 | 2 | 8 | | 2006 | 13 | 4 | 17 | | 2007 | 24 | 5 | 29 | | 2008 | 25 | 4 | 29 | | 2009 | 21 | 2 | 23 | | 2010 | 23 | 2 | 25 | | 2011 | 24 | 4 | 28 | | 2012 | 22 | 2 | 24 | | 2013 | 30 | 1 | 31 | | 2014 | 20 | 4 | 24 | | 2015 | 21 | 6 | 27 | | 2016 | 31 | 2 | 33 | | 2017 | 21 | 4 | 25 | | 2018 | 27 | 1 | 28 | | 2019 | 25 | 6 | 31 | | 2020 | 25 | 2 | 27 | | 2021 | 22 | 3 | 25 | | 2022 | 29 | 0 | 29 | | 2023 | 36 | 0 | 36 | | 2024 | 36 | 4 | 40 | | 2025 | 47 | 1 | 48 | | 2026 | 7 | 1 | 8 |
To return to the timeline, click here.
Below are the most recent publications written about "Liver Neoplasms" by people in Profiles.
-
Endo Y, Kawashima J, Chatzipanagiotou O, Woldesenbet S, Aucejo F, Marques HP, Lam V, Lesurtel M, Popescu I, Weiss M, Martel G, Poultsides GA, Ruzzenente A, Endo I, Gleisner A, Shen F, Pawlik TM. Machine learning-based clustering differentiates bilateral hepatocellular carcinoma characteristics and prognosis. Surgery. 2026 Jun; 194:110186.
-
Faseh L, Fruhling P, Taflin H, Lundmark Rystedt J, Williamsson C, Hemmingsson O, Björnsson B, Gerling M, Sparrelid E, Sandström P, Hasselgren K, Engstrand J. Real-world management of patients with simultaneously diagnosed synchronous liver and lung metastatic colorectal cancer - a national cohort study. Acta Oncol. 2026 Mar 12; 65:201-212.
-
Modanwal G, Kumar S, Viswanathan V, Morin CE, Rees MA, Squires JH, Tang ER, Katzenstein HM, Towbin AJ, Madabhushi A, Schooler GR. Pediatric Personalized Deep Learning Models for Segmentation of Hepatoblastoma at CT and MRI. Radiol Imaging Cancer. 2026 03; 8(2):e250041.
-
Cerbone L, Roviello G, Calabrò F, Taha T, Grande E, Binz K, Kanesvaran R, Pirstuk A, Fiala O, Molina-Cerrillo J, Alonso-Gordoa T, Rizzo A, Pichler R, Myint ZW, Poprach A, Facchini G, Bohuslav M, Studentova H, Morelli F, Buchler T, Mennitto A, Tural D, Formisano L, Orejana I, Catalano M, Buti S, Monteiro FSM, Soares A, Gupta S, Massari F, Santoni M. Liver metastases in advanced urothelial carcinoma (ARON-2): do pembrolizumab and avelumab make a difference in a poor-prognosis scenario? Front Immunol. 2026; 17:1667155.
-
Gu W, Ren Z, Gao J, Shen Z, Wang Y, Xu L, Qian R, Miao Q, Wu Y, Hu X, Wu Y, Liu W, Wan CC, Sun L, Cai Y, Sang M, Zheng C, Yan T. Inhibiting NAT10 suppresses hepatocellular carcinoma progression by reducing Nrf2 mRNA stability and increasing oxidative stress. Chem Biol Interact. 2026 Apr 25; 429:111972.
-
Malavia M, Eliason G, Eggers LA, Arne A, Marchak K, Hart J, Lindquist J, Trivedi P, Casadaban L. Yttrium-90 radioembolization for primary and metastatic liver tumors exhibiting arterial-phase hypovascularity. Sci Rep. 2026 Jan 15; 16(1):4588.
-
Tsybulskyi D, Hashimoto D, Tanaka K, Murotani K, Taguri M, Yamaki S, Sato S, Oba A, Inoue Y, Otsuka S, Ohgi K, Sugiura T, Shintakuya R, Okada K, Uemura K, Inoue K, Mizuma M, Unno M, Asano T, Nakagawa N, Takami H, Takahashi R, Motoi F, Akahoshi K, Ban D, Gulla A, Ishikawa H, Hirano S, Satoi S. Survival Impact After Resection for Postoperative Recurrence or Metastasis of Pancreatic Ductal Adenocarcinoma Analyzed Using a Time-Dependent Cox Regression Model. J Hepatobiliary Pancreat Sci. 2026 Mar; 33(3):216-227.
-
Baba H, Inoue Y, Kobayashi K, Oba A, Ono Y, Sato T, Ito H, Takahashi Y. Robotic Liver Resection With Scope Transition Technique: A Single-Center Experience. Asian J Endosc Surg. 2026 Jan-Dec; 19(1):e70230.
-
Afyouni S, Zandieh G, Pawlik TM, Kamel IR. Functional imaging: a game changer for biomarker discovery and treatment response among patients with hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol. 2026 Jan; 20(1):29-38.
-
Ito R, Oba A, Baba H, Shimane G, Sugiura K, Sawa Y, Shibata Y, Kiritani S, Kobayashi K, Ono Y, Inoue Y, Ito H, Yoshioka R, Mise Y, Saiura A, Takahashi Y. A Widely Applicable CAD-Based Intraoperative 3D Navigation Method for Hepatopancreatobiliary Surgery. Ann Surg Oncol. 2026 Apr; 33(4):3421-3422.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|